Vesalio's NeVa Neurothrombectomy Device Earns CE Mark Approval

 

October 31, 2017—Vesalio, LLC announced CE Mark approval of its first product line, the NeVa neurothrombectomy platform for the treatment of strokes. The NeVa mechanical thrombectomy technology was designed to improve “first-pass” success, by effectively capturing and removing a clot that creates a sudden blockage in the blood flow to the brain.

The company advised that it will initiate the product launch in Europe. Vesalio was founded in 2013 and is headquartered in Nashville, Tennessee.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.